The large-scale study that looked at Medicare recipients and cognitive impairment conditions like Alzheimer's since the ACA.

A new look at Indiana Alzheimer's numbers shows in 2015 at least 2,513 Hoosiers died from the disease, a 14 percent increase from the previous year. The report also estimates Indiana Medicaid spending will top $980 million.

The longterm, multi-site study is backed by 7.6 million in funding from the NIH.

An Alzheimer's study being conducted partially in Indianapolis uses brain imaging to follow the disease progression.

The IU School of Medicine received $7.6 million to lead a study that will create a network of sites to study early-onset Alzheimer's.

An Indiana woman named to an national Early-Stage Advisory Group for the Alzheimer's Association stresses the importance of research and reducing stigma.

In 2011, just more than 2,000 Alzheimer's deaths were recorded in Indiana. But in 2015 - the most recent year with state data - that figure had climbed by more than a quarter, to more than 2,500.

The students are helping these seniors create customized playlists that can help trigger memories.

Eli Lilly's Solanezumab was a medicine that aimed to reduce symptoms in patients with mild dementia due to Alzheimer's.

The news of layoffs follows last month's announcement concerning the failure of Solanezumab, which Lilly hoped would be the first drug to slow the progression of Alzheimer's Disease.